Researchers at UPMC Mercy Center for Healing and Amputation Prevention in Pittsburgh examined 2,060 consecutive surgical cases in four groups. Group one included nondiabetic patients with neuropathy, group 2 was comprised of nondiabetic patients with neuropathy, group 3 was patients with diabetes but with no complications, and group four was diabetic patients with complications.
The SSI rate in the study was 3.1 percent, and patients with complicated diabetes had a 7.25-fold increased risk of SSIs compared with nondiabetic patients without neuropathy, and a 3.72-fold increased risk compared to nondiabetic patients with neuropathy. On the other hand, patients with diabetes without complications did not have a greater SSI risk.
Additionally, researchers found that the presence of neuropathy increases the risk of surgical site infections even in patients without diabetes.
More Articles on Infection Prevention:
Hand Hygiene Video Wins APIC Conference Film Festival
Lyme Disease Tests Common, Costly: Study
18 Hospitals, Health Systems That Recently Added UV Disinfection Robots
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
